Updates are available Correction dated 2022-08-20
Click to view Correction: https://doi.org/10.1007/s00415-022-11321-6
-
Authors
Garrì, Federica https://orcid.org/0000-0002-3555-3882
Russo, Francesco Paolo
Carrer, Tommaso
Weis, Luca
Pistonesi, Francesca
Mainardi, Michele
Sandre, Michele
Savarino, Edoardo
Farinati, Fabio
Del Sorbo, Francesca
Soliveri, Paola
Calandrella, Daniela
Biundo, Roberta
Carecchio, Miryam
Zecchinelli, Anna Lena
Pezzoli, Gianni
Antonini, Angelo https://orcid.org/0000-0003-1040-2807
-
Funding
Funding for this research was provided by:
Università degli Studi di Padova
- License Information
-
More Information
Article History
Received: 1 April 2022
Revised: 2 July 2022
Accepted: 4 July 2022
First Online: 25 July 2022
Change Date: 20 August 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00415-022-11321-6
Declarations
:
: Angelo Antonini has received compensation for consultancy and speaker related activities from UCB, Boehringer Ingelheim, Ever Pharma, General Electric, Britannia, AbbVie, Kyowa Kirin, Zambon, Bial, Theravance Biopharma, Jazz Pharmaceuticals, Roche, Medscape; he receives research support from Bial, Lundbeck, Roche, Angelini Pharmaceuticals, Horizon 2020—Grant 825785, Horizon2020 Grant 101016902, Ministry of Education University and Research (MIUR) Grant ARS01_01081, Cariparo Foundation, Movement Disorders Society for NMS Scale validation. He serves as consultant for Boehringer–Ingelheim for legal cases on pathological gambling.<b>Ethical declaration</b>The study was conducted in accordance with the Good Clinical Practice and the International Conference on Harmonization guidelines and any applicable national and local regulations. The authors acted in accordance with the Declaration of Helsinki ethical standards.
